Isoimperatorin ameliorates osteoarthritis by downregulating the mammalian target of rapamycin C1 signaling pathway

Ouyang,Jiayao; Jiang,Huaji; Fang,Hang; Cui,Wenbo; Cai,Daozhang

doi:10.3892/mmr.2017.7777

Isoimperatorin ameliorates osteoarthritis by downregulating the mammalian target of rapamycin C1 signaling pathway

Authors:
- Jiayao Ouyang
- Huaji Jiang
- Hang Fang
- Wenbo Cui
- Daozhang Cai
View Affiliations

Affiliations: Department of Orthopaedics, The Third Affiliated Hospital of Southern Medical University, Guangzhou, Guangdong 510630, P.R. China, Department of Pain, Yue Bei People's Hospital, Shaoguan, Guangdong 512000, P.R. China, Department of Orthopaedics, Dongguan Eighth People's Hospital, Dongguan, Guangdong 523326, P.R. China
Published online on: October 12, 2017 https://doi.org/10.3892/mmr.2017.7777
Pages: 9636-9644

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteoarthritis (OA) is the most common disease of the joints, and is characterized by the breakdown of cartilage and degradation of the extracellular matrix. OA causes a high level of patient suffering and incurs large societal costs; however, the current strategies for treating OA are restricted due to limited understanding of the underlying molecular and cellular mechanisms. In the present study, the beneficial effects of isoimperatorin (Iso) were investigated using an experimental mouse model of OA, and its mechanism of action on primary chondrocytes was elucidated. Destabilization of the medial meniscus was performed on 8‑week‑old male mice to induce OA in the knees. Iso (500 mg/g/day) was intragastrically administered for 4 weeks. Degeneration of articular cartilage was assessed by histology using the Osteoarthritis Research Society International scoring system. The expression of matrix metalloproteinase (MMP)13, Runt‑related transcription factor (Runx)2, type X collagen (Col X) and vascular endothelial growth factor (VEGF) in the knee joints was examined by immunohistochemistry. In vitro, murine primary chondrocytes were treated with various concentrations of Iso, followed by 10 ng/ml interleukin‑1. The mRNA expression levels of MMP13, Runx2, Col X and VEGF were determined by reverse transcription‑quantitative polymerase chain reaction. The levels of autophagy and mammalian target of rapamycin (mTOR) signaling were determined by western blotting. Iso significantly ameliorated the severity of articular cartilage degradation in mice with experimental OA. The expression levels of MMP13, Runx2, Col X and VEGF were reduced in Iso‑treated mice. In murine primary chondrocytes, Iso also reduced MMP13, Runx2, Col X and VEGF expression, and activated autophagy by downregulating the mTOR complex 1 (mTORC1) signaling pathway. Therefore, the results of the present study demonstrated that Iso ameliorates OA‑induced pathological alterations by delaying chondrocyte deterioration, activating autophagy and inhibiting mTORC1, which suggests that Iso may have therapeutic potential for attenuating articular cartilage degradation and treating OA.

View Figures

View References

1	Losina E, Weinstein AM, Reichmann WM, Burbine SA, Solomon DH, Daigle ME, Rome BN, Chen SP, Hunter DJ, Suter LG, et al: Lifetime risk and age at diagnosis of symptomatic knee osteoarthritis in the US. Arthritis Care Res (Hoboken). 65:703–711. 2013. View Article : Google Scholar : PubMed/NCBI
2	Musumeci G, Aiello F, Szychlinska M, Di Rosa M, Castrogiovanni P and Mobasheri A: Osteoarthritis in the XXIst century: Risk factors and behaviours that influence disease onset and progression. Int J Mol Sci. 16:6093–6112. 2015. View Article : Google Scholar : PubMed/NCBI
3	Musumeci G, Szychlinska MA and Mobasheri A: Age-related degeneration of articular cartilage in the pathogenesis of osteoarthritis: Molecular markers of senescent chondrocytes. Histol Histopathol. 30:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
4	Aigner T, Sachse A, Gebhard PM and Roach HI: Osteoarthritis: Pathobiology-targets and ways for therapeutic intervention. Adv Drug Deliv Rev. 58:128–149. 2006. View Article : Google Scholar : PubMed/NCBI
5	Jacques C, Gosset M, Berenbaum F and Gabay C: The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation. Vitam Horm. 74:371–403. 2006. View Article : Google Scholar : PubMed/NCBI
6	Loeser RF, Goldring SR, Scanzello CR and Goldring MB: Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum. 64:1697–1707. 2012. View Article : Google Scholar : PubMed/NCBI
7	Yuan Q, Sun L, Li JJ and An CH: Elevated VEGF levels contribute to the pathogenesis of osteoarthritis. BMC Musculoskelet Disord. 15:4372014. View Article : Google Scholar : PubMed/NCBI
8	Musumeci G, Carnazza ML and Loreto C, Leonardi R and Loreto C: β-Defensin-4 (HBD-4) is expressed in chondrocytes derived from normal and osteoarthritic cartilage encapsulated in PEGDA scaffold. Acta Histochem. 114:805–812. 2012. View Article : Google Scholar : PubMed/NCBI
9	Musumeci G, Carnazza ML, Leonardi R and Loreto C: Expression of β-defensin-4 in ‘an in vivo and ex vivo model’ of human osteoarthritic knee meniscus. Knee Surg Sports Traumatol Arthrosc. 20:216–222. 2012. View Article : Google Scholar : PubMed/NCBI
10	Philp AM, Davis ET and Jones SW: Developing anti-inflammatory therapeutics for patients with osteoarthritis. Rheumatology (Oxford). 56:869–881. 2017.PubMed/NCBI
11	Goldring MB and Goldring SR: Osteoarthritis. J Cell Physiol. 213:626–634. 2007. View Article : Google Scholar : PubMed/NCBI
12	Wang S, Chen Q and He L: Development and validation of a gas chromatography-mass spectrometry method for the determination of isoimperatorin in rat plasma and tissue: Application to the pharmacokinetic and tissue distribution study. J Chromatogr B Analyt Technol Biomed Life Sci. 852:473–478. 2007. View Article : Google Scholar : PubMed/NCBI
13	Wei Y and Ito Y: Preparative isolation of imperatorin, oxypeucedanin and isoimperatorin from traditional Chinese herb ‘bai zhi’ Angelica dahurica (Fisch. ex Hoffm) Benth. et Hook using multidimensional high-speed counter-current chromatography. J Chromatogr A. 1115:112–117. 2006. View Article : Google Scholar : PubMed/NCBI
14	Kang OH, Chae HS, Oh YC, Choi JG, Lee YS, Jang HJ, Kim JH, Kim YC, Sohn DH, Park H and Kwon DY: Anti-nociceptive and anti-inflammatory effects of Angelicae dahuricae radix through inhibition of the expression of inducible nitric oxide synthase and NO production. Am J Chin Med. 36:913–928. 2008. View Article : Google Scholar : PubMed/NCBI
15	Zheng YM, Shen JZ, Wang Y, Lu AX and Ho WS: Anti-oxidant and anti-cancer activities of Angelica dahurica extract via induction of apoptosis in colon cancer cells. Phytomedicine. 23:1267–1274. 2016. View Article : Google Scholar : PubMed/NCBI
16	Nie H, Meng LZ, Zhou JY, Fan XF, Luo- Y and Zhang GW: Imperatorin is responsible for the vasodilatation activity of Angelica Dahurica var. Formosana regulated by nitric oxide in an endothelium-dependent manner. Chin J Integr Med. 15:442–447. 2009. View Article : Google Scholar : PubMed/NCBI
17	Chen YF, Tsai HY and Wu TS: Anti-inflammatory and analgesic activities from roots of Angelica pubescens. Planta Med. 61:2–8. 1995. View Article : Google Scholar : PubMed/NCBI
18	Moon TC, Jin M, Son JK and Chang HW: The effects of isoimperatorin isolated from Angelicae dahuricae on cyclooxygenase-2 and 5-lipoxygenase in mouse bone marrow-derived mast cells. Arch Pharm Res. 31:210–215. 2008. View Article : Google Scholar : PubMed/NCBI
19	Ban HS, Lim SS, Suzuki K, Jung SH, Lee S, Lee YS, Shin KH and Ohuchi K: Inhibitory effects of furanocoumarins isolated from the roots of Angelica dahurica on prostaglandin E2 production. Planta Med. 69:408–412. 2003. View Article : Google Scholar : PubMed/NCBI
20	Moon L, Ha YM, Jang HJ, Kim HS, Jun MS, Kim YM, Lee YS, Lee DH, Son KH, Kim HJ, et al: Isoimperatorin, cimiside E and 23-O-acetylshengmanol-3-xyloside from Cimicifugae rhizome inhibit TNF-α-induced VCAM-1 expression in human endothelial cells: Involvement of PPAR-γ upregulation and PI3K, ERK1/2 and, PKC signal pathways. J Ethnopharmacol. 133:336–344. 2011. View Article : Google Scholar : PubMed/NCBI
21	Glasson SS, Chambers MG, Van Den Berg WB and Little CB: The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse. Osteoarthritis Cartilage. 18 Suppl 3:S17–S23. 2010. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Lotz M and Caramés B: Autophagy: A new therapeutic target in cartilage injury and osteoarthritis. J Am Acad Orthop Surg. 20:261–262. 2012. View Article : Google Scholar : PubMed/NCBI
24	Vasheghani F, Zhang Y, Li YH, Blati M, Fahmi H, Lussier B, Roughley P, Lagares D, Endisha H, Saffar B, et al: PPARγ deficiency results in severe, accelerated osteoarthritis associated with aberrant mTOR signalling in the articular cartilage. Ann Rheum Dis. 74:569–578. 2015. View Article : Google Scholar : PubMed/NCBI
25	Guba M, von Breitenbuch P, Steinbauer M, Koehl G, Flegel S, Hornung M, Bruns CJ, Zuelke C, Farkas S, Anthuber M, et al: Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: Involvement of vascular endothelial growth factor. Nat Med. 8:128–135. 2002. View Article : Google Scholar : PubMed/NCBI
26	Laplante M and Sabatini DM: Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci. 126:1713–1719. 2013. View Article : Google Scholar : PubMed/NCBI
27	Berenbaum F, Griffin TM and Liu-Bryan R: Review: Metabolic regulation of inflammation in osteoarthritis. Arthritis Rheumatol. 69:9–21. 2017. View Article : Google Scholar : PubMed/NCBI
28	van der Kraan PM and van den Berg WB: Chondrocyte hypertrophy and osteoarthritis: Role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage. 20:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
29	Higashikawa A, Saito T, Ikeda T, Kamekura S, Kawamura N, Kan A, Oshima Y, Ohba S, Ogata N, Takeshita K, et al: Identification of the core element responsive to runt-related transcription factor 2 in the promoter of human type X collagen gene. Arthritis Rheum. 60:166–178. 2009. View Article : Google Scholar : PubMed/NCBI
30	Kamekura S, Kawasaki Y, Hoshi K, Shimoaka T, Chikuda H, Maruyama Z, Komori T, Sato S, Takeda S, Karsenty G, et al: Contribution of runt-related transcription factor 2 to the pathogenesis of osteoarthritis in mice after induction of knee joint instability. Arthritis Rheum. 54:2462–2470. 2006. View Article : Google Scholar : PubMed/NCBI
31	Yi JW, Lee WS, Kim SB, Heo YM and Chae DS: Effect of zoledronate on the expression of vascular endothelial growth factor-A by articular chondrocytes and synovial cells: An in vitro study. J Bone Metab. 21:249–255. 2014. View Article : Google Scholar : PubMed/NCBI
32	Neve A, Cantatore FP, Corrado A, Gaudio A, Ruggieri S and Ribatti D: In vitro and in vivo angiogenic activity of osteoarthritic and osteoporotic osteoblasts is modulated by VEGF and vitamin D3 treatment. Regul Pept. 184:81–84. 2013. View Article : Google Scholar : PubMed/NCBI
33	Takimoto A, Nishizaki Y, Hiraki Y and Shukunami C: Differential actions of VEGF-A isoforms on perichondrial angiogenesis during endochondral bone formation. Dev Biol. 332:196–211. 2009. View Article : Google Scholar : PubMed/NCBI
34	Saetan N, Honsawek S, Tanavalee A, Yuktanandana P, Meknavin S, Ngarmukos S, Tanpowpong T and Parkpian V: Relationship of plasma and synovial fluid vascular endothelial growth factor with radiographic severity in primary knee osteoarthritis. Int Orthop. 38:1099–1104. 2014. View Article : Google Scholar : PubMed/NCBI
35	Kim HR, Lee JH, Kim KW, Kim BM and Lee SH: The relationship between synovial fluid VEGF and serum leptin with ultrasonographic findings in knee osteoarthritis. Int J Rheum Dis. 19:233–240. 2016. View Article : Google Scholar : PubMed/NCBI
36	Nagai T, Sato M, Kobayashi M, Yokoyama M, Tani Y and Mochida J: Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis. Arthritis Res Ther. 16:4272014. View Article : Google Scholar : PubMed/NCBI
37	Nagai T, Sato M, Kutsuna T, Kokubo M, Ebihara G, Ohta N and Mochida J: Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair. Arthritis Res Ther. 12:R1782010. View Article : Google Scholar : PubMed/NCBI
38	Bouderlique T, Vuppalapati KK, Newton PT, Li L, Barenius B and Chagin AS: Targeted deletion of Atg5 in chondrocytes promotes age-related osteoarthritis. Ann Rheum Dis. 75:627–631. 2016. View Article : Google Scholar : PubMed/NCBI
39	Li YS, Zhang FJ, Zeng C, Luo W, Xiao WF, Gao SG and Lei GH: Autophagy in osteoarthritis. Joint Bone Spine. 83:143–148. 2016. View Article : Google Scholar : PubMed/NCBI
40	Caramés B, Taniguchi N, Otsuki S, Blanco FJ and Lotz M: Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis. Arthritis Rheum. 62:791–801. 2010. View Article : Google Scholar : PubMed/NCBI
41	Borzì RM, Guidotti S, Minguzzi M, Facchini A, Platano D, Trisolino G, Filardo G, Cetrullo S, D'Adamo S, Stefanelli C, et al: Polyamine delivery as a tool to modulate stem cell differentiation in skeletal tissue engineering. Amino Acids. 46:717–728. 2014. View Article : Google Scholar : PubMed/NCBI
42	Yang RT, Zhang C, Liu Y, Zhou HH and Li ZB: Autophagy prior to chondrocyte cell death during the degeneration of Meckel's cartilage. Anat Rec (Hoboken). 295:734–741. 2012. View Article : Google Scholar : PubMed/NCBI
43	Alvarez-García O, García-López E, Loredo V, Gil-Peña H, Rodríguez-Suárez J, Ordóñez FA, Carbajo-Pérez E and Santos F: Rapamycin induces growth retardation by disrupting angiogenesis in the growth plate. Kidney Int. 78:561–568. 2010. View Article : Google Scholar : PubMed/NCBI
44	Laplante M and Sabatini DM: Regulation of mTORC1and its impact on gene expression at a glance. J Cell Sci. 126:1713–1719. 2013. View Article : Google Scholar : PubMed/NCBI
45	Howell JJ, Ricoult SJ, Ben-Sahra I and Manning BD: A growing role for mTOR in promoting anabolic metabolism. Biochem Soc Trans. 41:906–912. 2013. View Article : Google Scholar : PubMed/NCBI
46	Caramés B, Hasegawa A, Taniguchi N, Miyaki S, Blanco FJ and Lotz M: Autophagy activation by rapamycin reduces severity of experimental osteoarthritis. Ann Rheum Dis. 71:575–581. 2012. View Article : Google Scholar : PubMed/NCBI
47	Bohensky J, Leshinsky S, Srinivas V and Shapiro IM: Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr Nephrol. 25:633–642. 2010. View Article : Google Scholar : PubMed/NCBI
48	Matsuzaki T, Matsushita T, Tabata Y, Saito T, Matsumoto T, Nagai K, Kuroda R and Kurosaka M: Intra-articular administration of gelatin hydrogels incorporating rapamycin-micelles reduces the development of experimental osteoarthritis in a murine model. Biomaterials. 35:9904–9911. 2014. View Article : Google Scholar : PubMed/NCBI
49	Takayama K, Kawakami Y, Kobayashi M, Greco N, Cummins JH, Matsushita T, Kuroda R, Kurosaka M, Fu FH and Huard J: Local intra-articular injection of rapamycin delays articular cartilage degeneration in a murine model of osteoarthritis. Arthritis Res Ther. 16:4822014. View Article : Google Scholar : PubMed/NCBI
50	Huang MJ, Wang L, Jin DD, Zhang ZM, Chen TY, Jia CH, Wang Y, Zhen XC, Huang B, Yan B, et al: Enhancement of the synthesis of n-3 PUFAs infat-1 transgenic mice inhibits mTORC1 signalling and delays surgically induced osteoarthritis in comparison with wild-type mice. Ann Rheum Dis. 73:1719–1727. 2014. View Article : Google Scholar : PubMed/NCBI
51	Zhang Y, Vasheghani F, Li YH, Blati M, Simeone K, Fahmi H, Lussier B, Roughley P, Lagares D, Pelletier JP, et al: Cartilage-specific deletion of mTOR upregulates autophagy and protects mice from osteoarthritis. Ann Rheum Dis. 74:1432–1440. 2015. View Article : Google Scholar : PubMed/NCBI
52	Alvarez-Garcia O, Olmer M, Akagi R, Akasaki Y, Fisch KM, Shen T, Su AI and Lotz MK: Suppression of REDD1 in osteoarthritis cartilage, a novel mechanism for dysregulated mTOR signaling and defective autophagy. Osteoarthritis Cartilage. 24:1639–1647. 2016. View Article : Google Scholar : PubMed/NCBI
53	Dell'Accio F and Sherwood J: PPARγ/mTOR signalling: Striking the right balance in cartilage homeostasis. Ann Rheum Dis. 74:477–479. 2015. View Article : Google Scholar : PubMed/NCBI
54	Chagin AS: Effectors of mTOR-autophagy pathway: Targeting cancer, affecting the skeleton. Curr Opin Pharmacol. 28:1–7. 2016. View Article : Google Scholar : PubMed/NCBI
55	Shi J, Zhang C, Yi Z and Lan C: Explore the variation of MMP3, JNK, p38 MAPKs, and autophagy at the early stage of osteoarthritis. IUBMB Life. 68:293–302. 2016. View Article : Google Scholar : PubMed/NCBI